US 9809541
LSD1 inhibitors
granted A61PA61P11/00A61P35/00
Quick answer
US patent 9809541 (LSD1 inhibitors) held by Mirati Therapeutics, Inc. expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mirati Therapeutics, Inc.
- Grant date
- Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 62
- CPC classes
- A61P, A61P11/00, A61P35/00, A61P43/00